Search
+
    SEARCHED FOR:

    INDIA STOCK MARKET

    NDA vs INDIA Bloc: Stock markets bleed on results day, investors lose Rs 30L Cr

    NDA vs INDIA Bloc: Stock markets bleed on results day, investors lose Rs 30L Cr

    On June 4th, the stock markets tumbled as India experienced its major event of the year. Despite exit polls favouring the NDA's victory, the actual results were unexpected. The Congress-led India bloc presented a solid challenge to the BJP-led NDA alliance, particularly ...

    Stock Radar I Time to buy? RSI oscillator is hinting at a positive momentum for Coal India: Ruchit Jain

    Stock Radar I Time to buy? RSI oscillator is hinting at a positive momentum for Coal India: Ruchit Jain

    “The stock was consolidating within a range since mid-February and prices have given a breakout from an ‘Inverted Head and Shoulders’ pattern on the daily chart. Traders can buy for a target of Rs 508 and a stop below Rs 457,” Ruchit Jain, Lead Re...

    Stock Radar I Why Havells India is a ‘buy on dips’ stock at current levels, decodes Ajit Mishra

    Stock Radar I Why Havells India is a ‘buy on dips’ stock at current levels, decodes Ajit Mishra

    “Havells has been a consistent performer in the consumer electrical space; maintaining a long-term uptrend since 2011. Traders can buy for a target of Rs 1850 in the next 1-2 months,” Ajit Mishra, SVP - Research, Religare Broking Ltd, said.Stock Radar I W...

    'BJP ki Line…': Rahul Gandhi snaps at journalist when questioned about alternative to JPC probe

    'BJP ki Line…': Rahul Gandhi snaps at journalist when questioned about alternative to JPC probe

    New Delhi: Rahul Gandhi addressed a press conference in New Delhi on June 06. During the conference, Gandhi snapped at a journalist who questioned Congress’ request for a Joint Parliamentary Committee in the alleged stock market scam. Rahul went on to ref...

    Fundamental Radar I Why does Piramal Pharma stock deserve a re-rating? Sandeep Raina explains

    Fundamental Radar I Why does Piramal Pharma stock deserve a re-rating? Sandeep Raina explains

    Piramal Pharma has a diversified business encompassing contract development and manufacturing business (CDMO), complex hospital generics (CHG), and India consumer healthcare (ICH). The CDMO business is grossly undervalued considering its potential in niche ...

    Fundamental Radar I What’s likely to drive volume growth, market share for Castrol India? Narendra Solanki explains

    Fundamental Radar I What’s likely to drive volume growth, market share for Castrol India? Narendra Solanki explains

    Castrol India has bolstered the presence of its products in 32,000 outlets deep in the rural hinterlands. The company’s primary focus will be on the Ki mobility partnership going forward, and Castrol’s alliance with the Jio-BP retail n...

    The Economic Times
    BACK TO TOP
    Advertisement